Michael Scolaro

Michael Scolaro

Nov 29, 2017

Group 6 Copy 173
1
References
  • 1. https://www.ncbi.nlm.nih.gov/pubmed/26558876
  • 2. https://www.ncbi.nlm.nih.gov/pubmed/26558876
Please wait...

About This Project

We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

Blast off!

Browse Other Projects on Experiment

Related Projects

Can Data Management Tools Improve Research Efficiency and Reproducibility?

Scientists are generating data at unprecedented rates, but our data management methods have yet to evolve accordingly...

Gila monster genomics: conservation, venom, and treatments for Type-II diabetes

The Gila monster, with its distinctive black and orange pattern, is one of Arizona’s most iconic animals. A...

What's Calcium's role in heart and kidney disease?

Hardening of the arteries, or atherosclerosis, is a global problem leading to heart attacks and strokes. Many...

Backer Badge Funded